References
- Sisson EM. Liraglutide: clinical pharmacology and considerations for therapy. Pharmacotherapy. 2011; 31: 896–911.
- Inzucchi SE, Bergenstal RM, Buse JB, etal. for the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012; 35: 1364–79.
- Reid T. Choosing GLP-1 receptor agonists or DPP-4 inhibitors: weighing the clinical trial evidence. Clin Diabetes. 2012; 30: 3–12.
- Truitt CA, Brooks DE, Skolnik A. Largest reported liraglutide overdose. 2011 North American Congress of Clinical Toxicology. Abstract 112, 21 Sep 2011. Available from: http://www.clintox.org/NACCT/2011/NACCT2011abstractsAllPoster.pdf. [cited 19 April 2013].
- Nakanishi R, Hirose T, Tamura Y, Fujitani Y, Watada H. Attempted suicide with liraglutide overdose did not induce hypoglycemia. Diabetes Res Clin Pract. 2013; 99(1): e3–4.
- Bode SF, Egg M, Wallesch C, Hermanns-Clausen M. 10-fold liraglutide overdose over 7 months resulted only in minor side-effects. J Clin Pharmacol. 2013; 53: 785–6.